Mayne Pharma Group Limited (MYX.AX)

AUD 4.85

(-2.02%)

Inventory Summary of Mayne Pharma Group Limited

Mayne Pharma Group Limited's latest annual inventory in 2024 was 74.62 Million AUD , down -9.76% from previous year.
Mayne Pharma Group Limited's latest quarterly inventory in 2024 FY was 74.62 Million AUD , down -9.76% from previous quarter.
Mayne Pharma Group Limited reported annual inventory of 82.7 Million AUD in 2023, down -24.06% from previous year.
Mayne Pharma Group Limited reported annual inventory of 108.9 Million AUD in 2022, up 6.24% from previous year.
Mayne Pharma Group Limited reported quarterly inventory of 74.62 Million AUD for 2024 FY, down -9.76% from previous quarter.
Mayne Pharma Group Limited reported quarterly inventory of 74.62 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of Mayne Pharma Group Limited (2024 - 2007)

Historical Annual Inventory of Mayne Pharma Group Limited (2024 - 2007)

Year	Inventory	Inventory Growth
2024	74.62 Million AUD	-9.76%
2023	82.7 Million AUD	-24.06%
2022	108.9 Million AUD	6.24%
2021	102.51 Million AUD	9.06%
2020	93.99 Million AUD	-6.33%
2019	100.34 Million AUD	22.14%
2018	82.15 Million AUD	-22.78%
2017	106.39 Million AUD	173.2%
2016	38.94 Million AUD	73.51%
2015	22.44 Million AUD	30.22%
2014	17.23 Million AUD	26.8%
2013	13.59 Million AUD	87.64%
2012	7.24 Million AUD	12.78%
2011	6.42 Million AUD	-1.18%
2010	6.49 Million AUD	0.0%
2009	- AUD	0.0%
2008	- AUD	0.0%
2007	- AUD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	91.9 Million AUD	0.0%
2024 FY	74.62 Million AUD	-9.76%
2024 Q4	74.62 Million AUD	0.0%
2023 FY	82.7 Million AUD	-24.06%
2023 Q4	82.7 Million AUD	0.0%
2023 Q2	125.31 Million AUD	0.0%
2022 Q2	111.88 Million AUD	0.0%
2022 Q4	108.9 Million AUD	0.0%
2022 FY	108.9 Million AUD	6.24%
2021 Q2	95.4 Million AUD	0.0%
2021 Q4	102.51 Million AUD	0.0%
2021 FY	102.51 Million AUD	9.06%
2020 FY	93.99 Million AUD	-6.33%
2020 Q4	93.99 Million AUD	0.0%
2020 Q2	93.34 Million AUD	0.0%
2019 Q2	100.64 Million AUD	0.0%
2019 FY	100.34 Million AUD	22.14%
2019 Q4	100.34 Million AUD	0.0%
2018 Q2	88.58 Million AUD	0.0%
2018 Q4	82.15 Million AUD	0.0%
2018 FY	82.15 Million AUD	-22.78%
2017 Q2	108.85 Million AUD	0.0%
2017 FY	106.39 Million AUD	173.2%
2017 Q4	106.39 Million AUD	0.0%
2016 Q4	38.94 Million AUD	0.0%
2016 FY	38.94 Million AUD	73.51%
2016 Q2	28.62 Million AUD	0.0%
2015 FY	22.44 Million AUD	30.22%
2015 Q2	19.97 Million AUD	0.0%
2015 Q4	22.44 Million AUD	0.0%
2014 Q2	17.18 Million AUD	0.0%
2014 Q4	17.23 Million AUD	0.0%
2014 FY	17.23 Million AUD	26.8%
2013 Q4	13.59 Million AUD	0.0%
2013 Q2	12.11 Million AUD	0.0%
2013 FY	13.59 Million AUD	87.64%
2013 Q3	13.59 Million AUD	12.23%
2012 FY	7.24 Million AUD	12.78%
2012 Q4	7.24 Million AUD	0.0%
2011 Q4	6.42 Million AUD	0.0%
2011 FY	6.42 Million AUD	-1.18%
2010 Q4	6.49 Million AUD	0.0%
2010 FY	6.49 Million AUD	0.0%
2009 Q4	- AUD	0.0%
2009 FY	- AUD	0.0%
2008 FY	- AUD	0.0%
2008 Q4	- AUD	0.0%
2007 Q4	- AUD	0.0%
2007 FY	- AUD	0.0%

Peer Inventory Comparison of Mayne Pharma Group Limited

Name	Inventory	Inventory Difference
Firebrick Pharma Limited	239.76 Thousand AUD	-31025.375%